Ignite Creation Date:
2025-12-25 @ 3:53 AM
Ignite Modification Date:
2026-05-17 @ 10:44 PM
Study NCT ID:
NCT01259102
Status:
COMPLETED
Last Update Posted:
2012-09-03
First Post:
2010-12-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Examine Plasma Concentrations of Buprenorphine Following Reapplication of Buprenorphine Transdermal System (BTDS) After Variable Application Site Rest Periods
Sponsor:
Purdue Pharma LP
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BUP1002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None